Insulin Aspart

Main Uses

Insulin aspart is prescribed to manage blood glucose (sugar) levels in people with diabetes. It is used for two primary conditions:

• Type 1 diabetes: A condition where the body does not produce insulin and therefore cannot control the amount of sugar in the blood.
• Type 2 diabetes: A condition where the body does not use insulin normally and cannot control the amount of sugar in the blood.

Mealtime Blood Sugar Control

This medication is a fast-acting form of insulin. It is typically used to manage the rise in blood sugar that occurs after eating. Because it works quickly, it is usually injected shortly before a meal or immediately after starting a meal.

In many cases, insulin aspart is used as part of a treatment regimen that includes a longer-acting insulin to provide baseline blood sugar control throughout the day and night. It may be administered via a syringe, an injection pen, or a continuous subcutaneous infusion pump.

Mechanism of Action

Insulin aspart is a man-made form of the hormone insulin that replaces the insulin naturally produced by the body. Its primary function is to regulate glucose metabolism, which is how the body processes sugar for energy.

When injected, insulin aspart works in several ways to lower blood sugar levels:

• Glucose Uptake: It helps move sugar from the blood into peripheral tissues, such as skeletal muscle and fat, where it can be used as fuel.
• Liver Regulation: It signals the liver to stop producing and releasing more sugar into the bloodstream.
• Metabolic Support: It helps the body properly store and use carbohydrates, proteins, and fats.

Timing and Absorption

As a rapid-acting insulin, insulin aspart is absorbed more quickly into the bloodstream than regular human insulin. This allows it to work faster to manage blood sugar spikes that occur after eating. The timing of its effects generally follows this pattern:

• Onset: It begins to lower blood sugar within approximately 15 minutes after injection.
• Peak: It reaches its maximum effect about 1 hour after injection.
• Duration: It continues to work in the body for approximately 2 to 4 hours.

Common Side Effects

The most common side effect of insulin aspart is hypoglycemia (low blood sugar). Other common side effects include:

• Injection site reactions, such as pain, redness, swelling, or itching.
• Lipodystrophy, which is a change in skin thickness or pitting at the injection site.
• Weight gain.
• Mild skin rash or itching.
• Swelling of the hands or feet (edema).
• Headache or symptoms of an upper respiratory tract infection.

Serious Side Effects

Some side effects can be serious. Seek medical attention immediately if you experience any of the following:

• Severe hypoglycemia: Symptoms may include confusion, dizziness, blurred vision, slurred speech, tremors, seizures, or loss of consciousness.
• Severe allergic reaction: Signs include a rash over the whole body, trouble breathing, fast heartbeat, sweating, or swelling of the face, tongue, or throat.
• Low potassium (hypokalemia): Symptoms include muscle cramps, weakness, or an abnormal heart rhythm.
• Heart failure: New or worsening shortness of breath, swelling of the ankles or feet, or sudden weight gain.

Hypoglycemia

Hypoglycemia, or low blood sugar, is the most common adverse reaction associated with insulin aspart and can be life-threatening. The risk of hypoglycemia increases with changes in insulin dose, co-administered glucose-lowering medications, meal patterns, and physical activity. Severe hypoglycemia can cause seizures, unconsciousness, or death.

Hypersensitivity Reactions

Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with insulin products. Symptoms may include a whole-body rash, shortness of breath, wheezing, fast pulse, or sweating. If a serious allergic reaction occurs, the medication must be stopped immediately.

Hypokalemia

All insulin products cause a shift in potassium from the extracellular to intracellular space, which can lead to hypokalemia (low potassium). If left untreated, low potassium can cause respiratory paralysis, heart rhythm irregularities, and death. Monitoring is especially important for patients at risk, such as those using potassium-lowering medications.

Fluid Retention and Heart Failure

Fluid retention and heart failure have been reported when insulin is used in combination with thiazolidinediones (TZDs). Patients should be monitored for signs of heart failure, such as shortness of breath, swelling of the ankles or feet, and sudden weight gain.

Medication Errors

Accidental mix-ups between insulin aspart and other insulins have been reported. To avoid medication errors, the insulin label should always be checked before each injection to ensure the correct product is being used.

Never Share Pens or Needles

Insulin aspart delivery devices, such as prefilled pens or syringes, must never be shared between patients, even if the needle is changed. Sharing these devices poses a risk for the transmission of bloodborne pathogens.

Renal and Hepatic Impairment

Patients with kidney or liver disease may require more frequent blood glucose monitoring and dose adjustments, as these conditions can affect how the body processes insulin.

Pregnancy

Maintaining stable blood sugar levels is essential during pregnancy to reduce the risk of complications for both the parent and the baby. Research and clinical data suggest that insulin aspart does not increase the risk of major birth defects, miscarriage, or other adverse outcomes compared to other insulin products.

Insulin needs often change throughout the course of a pregnancy:

• First trimester: Insulin requirements may decrease.
• Second and third trimesters: Insulin requirements typically increase significantly.
• Postpartum: After delivery, insulin needs usually return to pre-pregnancy levels or change again, especially if breastfeeding.

Breastfeeding

It is generally considered safe to use insulin aspart while breastfeeding. Insulin is a natural component of human milk, and the medication is not expected to cause harm to a nursing infant. However, breastfeeding can affect blood glucose levels, and insulin doses may need to be adjusted accordingly.

Individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss their treatment plan and blood sugar monitoring with their healthcare provider to ensure appropriate dosage adjustments.

Available Forms

Insulin aspart is a clear, colorless solution for injection. It is available in several delivery formats designed for different administration needs:

• Vials: Multi-dose containers used with traditional insulin syringes or for filling the reservoirs of external insulin infusion pumps.
• Prefilled Pens: Disposable, single-patient-use devices that come pre-loaded with the medication.
• Cartridges: Containers designed for use with specific reusable insulin pen delivery systems.

Methods of Administration

This medication is administered through the following routes:

• Subcutaneous Injection: Injected into the fatty tissue just under the skin, typically in the abdomen, thigh, upper arm, or buttocks.
• Continuous Subcutaneous Infusion: Delivered through an external insulin pump system.
• Intravenous Infusion: Administered directly into a vein by a healthcare professional in a clinical setting when immediate medical supervision is required.

FDA Approval and Indications

Insulin aspart is approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar levels in patients with type 1 and type 2 diabetes. It is approved for use in both adult and pediatric populations. The medication is available in several formulations, including rapid-acting injections and pre-mixed versions that combine insulin aspart with insulin aspart protamine.

Regulatory History and Biosimilars

The FDA has approved several brand-name versions of insulin aspart, as well as interchangeable biosimilar products. An interchangeable biosimilar designation allows the medication to be substituted for the reference product at the pharmacy level without a new prescription from a healthcare provider, depending on specific state laws.

Safety Monitoring and Communications

The FDA monitors the safety of insulin aspart through the FDA Adverse Event Reporting System (FAERS). In early 2018, the FDA identified a potential signal of serious risk regarding medication errors, specifically involving mix-ups between different insulin products. To address these risks, regulatory guidance emphasizes the importance of clear labeling and patient education to ensure the correct insulin type and dose are administered.

Boxed Warnings and REMS

Insulin aspart does not currently have a boxed warning, which is the FDA's most serious warning level. Additionally, there is no Risk Evaluation and Mitigation Strategy (REMS) required for this medication. However, the FDA requires all insulin products to include prominent warnings regarding the risks of hypoglycemia (low blood sugar) and hypokalemia (low potassium levels).

Weight Changes and Insulin Aspart

Weight gain is a common side effect of insulin therapy, including insulin aspart. This occurs because insulin helps the body's cells absorb glucose (sugar) from the bloodstream. When blood sugar levels are better controlled, the body may store excess calories that were previously lost through the urine when blood sugar was high.

Factors Contributing to Weight Gain

Several factors can lead to weight changes while using insulin aspart:

• Improved glucose absorption: As insulin works to lower blood sugar, the body begins to store energy more efficiently rather than excreting excess sugar.
• Caloric intake: If a person consumes more calories than their body needs while on insulin, the extra energy is often stored as fat.
• Treating low blood sugar: Managing episodes of hypoglycemia (low blood sugar) often requires consuming extra calories in the form of glucose tablets, juice, or snacks, which can contribute to weight gain over time.

It is important to follow the diet and exercise plan recommended by a healthcare provider while using insulin aspart. If you experience significant or unexpected weight gain, consult your doctor to discuss adjustments to your treatment plan or lifestyle routine.